New

NeedleAID by DECAP

The AI engine Fit Assessment

Beta

The company will be attending ViVE 2025 Event

Blurb

Developer of needle safety devices for healthcare, veterinary, and research workers. NeedleAID by DECAP Research and Development offers safer solutions for clinics, hospitals, and at-home use, with a design that reduces the risk of needlestick injuries.

HQ Location

Canada

Founded

2018

Employees

1 - 10

Total funding raised

Not available

Last Funding Event

Not available

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M

Developer of needle safety devices for healthcare, veterinary, and research workers. NeedleAID by DECAP Research and Development offers safer solutions for clinics, hospitals, and at-home use, with a design that reduces the risk of needlestick injuries. The company meets regulatory standards for needle safety in Canada, the USA, and the EU. NeedleAID has been tested in over 100 laboratory, research, and clinical environments over the past 3 years.